Difficulty: Medium
Average Score: 67%
Practice
A 17-year-old female adolescent wishes to have the human papilloma virus (HPV) immunisation. She also asks several questions. Which of the following statements is CORRECT?
Correct answer
C
Rationale
The correct answer is C) A series of 3 injections of the HPV vaccine is recommended. This statement is correct because the HPV vaccine is typically administered in a series of three doses to provide optimal protection against HPV infection. The dosing schedule usually involves the first dose, followed by a second dose 1-2 months later, and a third dose 6 months after the first dose.
Option A is incorrect because the eligible age group for HPV immunization is typically recommended for both males and females between the ages of 9 to 26 years.
Option B is incorrect because the HPV vaccine is available in several formulations, including bivalent, quadrivalent, and nonavalent vaccines, but not trivalent.
Option D is incorrect because in many countries, including the USA, HPV immunization is eligible for insurance coverage and may be reimbursable through health savings accounts or flexible spending accounts. It is essential for healthcare providers to educate patients and their families about the importance of completing the full HPV vaccine series to ensure maximum protection against HPV-related diseases, including cervical cancer.
Option A is incorrect because the eligible age group for HPV immunization is typically recommended for both males and females between the ages of 9 to 26 years.
Option B is incorrect because the HPV vaccine is available in several formulations, including bivalent, quadrivalent, and nonavalent vaccines, but not trivalent.
Option D is incorrect because in many countries, including the USA, HPV immunization is eligible for insurance coverage and may be reimbursable through health savings accounts or flexible spending accounts. It is essential for healthcare providers to educate patients and their families about the importance of completing the full HPV vaccine series to ensure maximum protection against HPV-related diseases, including cervical cancer.